Literature DB >> 28640667

Restricting retrotransposons: ADAR1 is another guardian of the human genome.

Elisa Orecchini1, Loredana Frassinelli1, Alessandro Michienzi1.   

Abstract

ADAR1 is an enzyme that belongs to the Adenosine Deaminases Acting on RNA (ADARs) family. These enzymes deaminate adenosines to inosines (RNA editing A-to-I) within double-stranded RNA regions in transcripts. Since inosines are recognized as guanosines by the cellular machinery, RNA editing mediated by ADARs can either lead to the formation of an altered protein (recoding) or affect different aspects of RNA metabolism. Recently, a proteomic analysis led to the identification of novel ADAR1-associated factors and found that a good fraction of them is shared with the Long Interspersed Element 1 (LINE-1 or L1) ribonucleoparticles (RNPs). This evidence suggested a possible role of ADAR1 in regulating the L1 life cycle. By taking advantage of the use of cell culture retrotransposition assays, a novel function of this deaminase as an inhibitor of L1 retrotransposition was demonstrated. These results pave the way toward a better comprehension of the mechanisms of restriction of retrotransposons.

Entities:  

Keywords:  ADAR1; Aicardi Goutières syndrome; Alu; LINE-1; Retrotransposon

Mesh:

Substances:

Year:  2017        PMID: 28640667      PMCID: PMC5785221          DOI: 10.1080/15476286.2017.1341033

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  78 in total

1.  ADAR2 editing enzyme is a novel human immunodeficiency virus-1 proviral factor.

Authors:  Margherita Doria; Sara Tomaselli; Francesca Neri; Silvia Anna Ciafrè; Maria Giulia Farace; Alessandro Michienzi; Angela Gallo
Journal:  J Gen Virol       Date:  2011-02-02       Impact factor: 3.891

Review 2.  Retrotransposons as regulators of gene expression.

Authors:  Reyad A Elbarbary; Bronwyn A Lucas; Lynne E Maquat
Journal:  Science       Date:  2016-02-11       Impact factor: 47.728

3.  Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition.

Authors:  Q Feng; J V Moran; H H Kazazian; J D Boeke
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

4.  Human L1 retrotransposition: cis preference versus trans complementation.

Authors:  W Wei; N Gilbert; S L Ooi; J F Lawler; E M Ostertag; H H Kazazian; J D Boeke; J V Moran
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

5.  Human LINE retrotransposons generate processed pseudogenes.

Authors:  C Esnault; J Maestre; T Heidmann
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

Review 6.  Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral.

Authors:  Charles E Samuel
Journal:  Virology       Date:  2011-01-05       Impact factor: 3.616

Review 7.  Cytosine methylation and the ecology of intragenomic parasites.

Authors:  J A Yoder; C P Walsh; T H Bestor
Journal:  Trends Genet       Date:  1997-08       Impact factor: 11.639

8.  LINE-mediated retrotransposition of marked Alu sequences.

Authors:  Marie Dewannieux; Cécile Esnault; Thierry Heidmann
Journal:  Nat Genet       Date:  2003-08-03       Impact factor: 38.330

9.  Trex1 prevents cell-intrinsic initiation of autoimmunity.

Authors:  Daniel B Stetson; Joan S Ko; Thierry Heidmann; Ruslan Medzhitov
Journal:  Cell       Date:  2008-08-22       Impact factor: 41.582

10.  The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.

Authors:  Niamh M Mannion; Sam M Greenwood; Robert Young; Sarah Cox; James Brindle; David Read; Christoffer Nellåker; Cornelia Vesely; Chris P Ponting; Paul J McLaughlin; Michael F Jantsch; Julia Dorin; Ian R Adams; A D J Scadden; Marie Ohman; Liam P Keegan; Mary A O'Connell
Journal:  Cell Rep       Date:  2014-11-13       Impact factor: 9.423

View more
  6 in total

1.  Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.

Authors:  Emily C Freund; Anne L Sapiro; Qin Li; Sandra Linder; James J Moresco; John R Yates; Jin Billy Li
Journal:  Cell Rep       Date:  2020-05-19       Impact factor: 9.423

Review 2.  Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases.

Authors:  Elisa Orecchini; Loredana Frassinelli; Silvia Galardi; Silvia Anna Ciafrè; Alessandro Michienzi
Journal:  Chromosome Res       Date:  2018-02-02       Impact factor: 5.239

Review 3.  RNA Editing and Retrotransposons in Neurology.

Authors:  Heinz Krestel; Jochen C Meier
Journal:  Front Mol Neurosci       Date:  2018-05-23       Impact factor: 5.639

4.  Genome and transcriptome mechanisms driving cephalopod evolution.

Authors:  Caroline B Albertin; Sofia Medina-Ruiz; Therese Mitros; Hannah Schmidbaur; Gustavo Sanchez; Z Yan Wang; Jane Grimwood; Joshua J C Rosenthal; Clifton W Ragsdale; Oleg Simakov; Daniel S Rokhsar
Journal:  Nat Commun       Date:  2022-05-04       Impact factor: 17.694

Review 5.  RNA editing in the forefront of epitranscriptomics and human health.

Authors:  Theodoulakis Christofi; Apostolos Zaravinos
Journal:  J Transl Med       Date:  2019-09-23       Impact factor: 5.531

6.  The RNA editing enzyme ADAR2 restricts L1 mobility.

Authors:  Loredana Frassinelli; Elisa Orecchini; Sofian Al-Wardat; Marco Tripodi; Carmine Mancone; Margherita Doria; Silvia Galardi; Silvia Anna Ciafrè; Alessandro Michienzi
Journal:  RNA Biol       Date:  2021-07-05       Impact factor: 4.652

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.